
Section 315(c) of the America Invents Act (“AIA”) provides that if the Director of the U.S. Patent and Trademark Office...
To learn about Mr. Lawson's practice, please visit http://www.rfem.com/professionals/lallen.
Section 315(c) of the America Invents Act (“AIA”) provides that if the Director of the U.S. Patent and Trademark Office...
Tagged with: AIA, Federal Circuit, IPR, PTAB, Self-joinder, USPTO
By Mark Rawls and D. Lawson Allen
The Patent Trial and Appeal Board (“the PTAB”) ruled last Friday, February 23, 2018, that tribal sovereign immunity does not apply to...
Tagged with: IPR, Patent, PTAB, Sovereign Immunity
The topic of sovereign immunity was raised a number of times in inter partes review (IPR) proceedings in 2017, and it was cast into the...
Tagged with: Federal Circuit, IPR, Patent, PTAB, Sovereign Immunity
Senior U.S. Circuit Judge William Bryson ruled on Monday that all the asserted claims in the six Restasis patents that Allergan PLC...
Tagged with: IPR, Obviousness, Patent, PTAB, Sovereign Immunity
Just recently, Allergan PLC (“Allergan”) announced that it had transferred the patents for its dry-eye drug Restasis to the Saint Regis...
Tagged with: IPR, Patent, PTAB, Sovereign Immunity